0001209191-23-017233.txt : 20230308
0001209191-23-017233.hdr.sgml : 20230308
20230308170042
ACCESSION NUMBER: 0001209191-23-017233
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230306
FILED AS OF DATE: 20230308
DATE AS OF CHANGE: 20230308
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Conner Edward R.
CENTRAL INDEX KEY: 0001691265
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41498
FILM NUMBER: 23716865
MAIL ADDRESS:
STREET 1: 501 CANAL BLVD.
STREET 2: POINT RICHMOND TECH CENTER
CITY: RICHMOND
STATE: CA
ZIP: 94804
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Third Harmonic Bio, Inc.
CENTRAL INDEX KEY: 0001923840
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 834553503
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1700 MONTGOMERY STREET
STREET 2: SUITE 210
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
BUSINESS PHONE: 2097272457
MAIL ADDRESS:
STREET 1: 1700 MONTGOMERY STREET
STREET 2: SUITE 210
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-03-06
0
0001923840
Third Harmonic Bio, Inc.
THRD
0001691265
Conner Edward R.
1700 MONTGOMERY STREET
SUITE 210
SAN FRANCISCO
CA
94111
0
1
0
0
Chief Medical Officer
Employee Stock Option (right to buy)
8.61
2023-03-06
4
D
0
383288
D
2032-07-27
Common Stock
383288
0
D
Employee Stock Option (right to buy)
4.20
2023-03-06
4
A
0
383288
A
2032-07-27
Common Stock
383288
383288
D
Employee Stock Option (right to buy)
18.40
2023-03-06
4
D
0
95000
D
2032-10-24
Common Stock
95000
0
D
Employee Stock Option (right to buy)
4.20
2023-03-06
4
A
0
95000
A
2032-10-24
Common Stock
95000
95000
D
Employee Stock Option (right to buy)
4.20
2023-03-06
4
A
0
137000
0.00
A
2033-03-05
Common Stock
137000
137000
D
The transaction reported herein reflects a one-time stock option repricing that became effective on March 6, 2023, and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options.
25% of the total shares vest on June 6, 2023, and thereafter 6.25% of the total shares underlying the award shall vest in equal quarterly installments until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
The option vests over a four-year period: 1/48th on November 25, 2022, after which 1/48th of the total shares vest monthly, subject to continued service through each vesting date.
The option vests over a four-year period: 1/48th on April 6, 2023, after which 1/48th of the total shares vest monthly, subject to continued service through each vesting date.
/s/ Robert Ho, Attoney-in-Fact
2023-03-08